1. Home
  2. CNTX vs NA Comparison

CNTX vs NA Comparison

Compare CNTX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

NA

Nano Labs Ltd

HOLD

Current Price

$2.27

Market Cap

46.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTX
NA
Founded
2015
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
46.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CNTX
NA
Price
$0.38
$2.27
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
1.7M
151.1K
Earning Date
05-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
17.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.58
52 Week High
$3.62
$6.10

Technical Indicators

Market Signals
Indicator
CNTX
NA
Relative Strength Index (RSI) 38.40 54.39
Support Level $0.34 $1.68
Resistance Level $0.70 $2.49
Average True Range (ATR) 0.02 0.21
MACD 0.01 -0.01
Stochastic Oscillator 73.14 41.04

Price Performance

Historical Comparison
CNTX
NA

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: